OrbiMed Provides $100MM Natera Facility
Natera, a provider of non-invasive genetic testing and analysis of circulating cell-free DNA, entered into a $100 million credit agreement with OrbiMed Royalty Opportunities II as the lender.
August 11, 2017
Natera | OrbiMed Advisors | OrbiMed Royalty Opportunities
Sam Nickerson